Moreover, the expression levels of MYL9 and TPM2, but not MSN were significantly associated with the advanced TNM stage (Supplementary Fig. 4E), implying that MYL9 and TPM2 may play a key role in tumor progression, and predicted a worse outcome in CRC. The gene discussed is MSN; the disease is neoplasm.